Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR
Med Research · 2025
DOI: 10.1002/mdr2.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Med Research, 2025. Verfasst von Yiran Fang und 5 weiteren Autor:innen. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The tumor microenvironment (TME) is a critical factor in antitumor immunity and treatment outcome in cancer therapy. We have developed an analysis tool called the immuno‐oncology biological research (IOBR) to investigate the TME and its role in antitumor immunity. Leveraging multi‐omics data, IOBR facilitates comprehensive analysis of TME characteristics, immune interactions, and their impact on immunotherapy outcomes. IOBR features six modules for TME analysis, including transcriptomic data preprocessing, TME profiling, TME pattern identification, ligand–receptor interaction analysis, genome‐TME interaction assessment, and visualization, along with modeling. Since its release, this tool has been widely applied in many studies. In the future, IOBR will gradually integrate TCR/BCR repertoire analysis, enhance genomic functionalities, and develop spatial transcriptomics modules, which will further our understanding of TME dynamics and tumor immunity.
Zitieren
APA
Fang, Y., Kong, Y., Rong, G., Luo, Q., Liao, W., & Zeng, D. (2025). Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR. Med Research. https://doi.org/10.1002/mdr2.70001
Vancouver
Fang Y, Kong Y, Rong G, Luo Q, Liao W, Zeng D. Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR. Med Research. 2025. doi:10.1002/mdr2.70001
BibTeX
@article{Fang2025,
author = {Fang, Yiran and Kong, Yuyun and Rong, Guangda and Luo, Qingcong and Liao, Wangjun and Zeng, Dongqiang},
title = {Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR},
journal = {Med Research},
year = {2025},
doi = {10.1002/mdr2.70001}
}
EUVIMED